<DOC>
	<DOCNO>NCT02963922</DOCNO>
	<brief_summary>This trial conduct globally . The aim trial investigate effect safety liraglutide 3.0 mg subject overweight obesity type 2 diabetes mellitus treat basal insulin .</brief_summary>
	<brief_title>Effect Safety Liraglutide 3.0 mg Subjects With Overweight Obesity Type 2 Diabetes Mellitus Treated With Basal Insulin</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Overweight</mesh_term>
	<mesh_term>Nutrition Disorders</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<criteria>Informed consent obtain trialrelated activity . Trialrelated activity procedure carry part trial , include activity determine suitability trial Diagnosed type 2 diabetes mellitus Treatment 2 OADs ( oral antidiabetic ) ( metformin , glitazone , SGLT2 inhibitor ( sodiumglucose cotransporter2 inhibitor ) sulphonylurea ) Stable treatment basal insulin accord label ( requirement minimum maximum dose ) least 90 day prior screen , judge investigator HbA1c ( glycosylated haemoglobin ) 6.010.0 % ( inclusive ) BMI ( body mass index ) equal 27 kg/m^2 Age least 18 year time signing informed consent Diagnosis type 1 diabetes Known hypoglycaemic unawareness indicate investigator accord Clarke 's questionnaire question 8 ( see Section 8.2.3 ) Recurrent severe hypoglycaemic episode within last year judge investigator Unable unwilling perform selfmonitoring plasma glucose accord protocol keep diabetes diary Treatment hypoglycaemic medication OADs basal insulin within past 90 day prior screen Treatment DPPIV ( dipeptidyl peptidase4 ) inhibitor within past 90 day prior screen Recent history cardiovascular disease ( myocardial infarction stroke within past 6 month ) , severe congestive heart failure ( NYHA class III , IV ) , second degree great heart block Personal family history Medullary Thyroid Carcinoma ( MTC ) Multiple Endocrine Neoplasia type 2 ( MEN2 ) Female pregnant , breastfeed intend become pregnant childbearing potential use adequate contraceptive method ( adequate contraceptive measure require local regulation practice ) For Germany : Only highly effective method birth control accept ( i.e . one result less 1 % per year failure rate use consistently correctly implant , injectables , combine oral contraceptive , intrauterine device ) , sexual abstinence vasectomise partner Use past 90 day medication know induce significant weight loss ( e.g. , prescription weight loss medication ) weight gain ( e.g. , chronic use oral steroid , second generation antipsychotic ) History pancreatitis ( acute chronic ) History major depressive disorder within past 2 year Any lifetime history suicide attempt Inadequately treat blood pressure define Grade 3 hypertension high ( Systolic equal 180 mmHg diastolic equal to110 mmHg ) . History malignancy ( except nonmelanoma skin cancer ) within past 5 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>